e-planning.net ad

Keegy United States

You are in Santa Monica Change
Choose your region and city

* Weather information available.

Search
19 Nov
Results

2 Votes vote

FDA grants orphan drug status to Reata's pancreatic cancer drug

Reata Pharmaceuticals, Inc. has announced that RTA 402 has been granted orphan drug designation by the U.S. Food and Drug Administration (FDA) for the treatment of pancreatic cancer. RTA 402 is currently being studied in a Phase 1/2 trial in patients with pancreatic cancer, and is also in Phase 2...

Bury News-Med...ews Feed — October 16

Receive news for reata

Video for reata

Images for reata